---
figid: PMC10177463__cancers-15-02607-g001
pmcid: PMC10177463
image_filename: PMC10177463__cancers-15-02607-g001.jpg
figure_link: /pmc/articles/PMC10177463/figure/F1/
number: Figure 1
figure_title: Schematic representation of alterations in the RAS-BRAF-MEK-ERK MAP
  kinase signaling pathway with V600-mutated BRAF and sites of therapeutic kinase
  inhibition.
caption: 'Schematic representation of alterations in the RAS-BRAF-MEK-ERK MAP kinase
  signaling pathway with V600-mutated BRAF and sites of therapeutic kinase inhibition.
  BRAFi: BRAF inhibitor; MEKi: MEK inhibitor'
article_title: 'BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance:
  An Update of the Current Knowledge'
citation: Laetitia Florent, et al. Cancers (Basel). 2023 May;15(9).
year: '2023'
pub_date: 2023-5-
epub_date: 2023-5-04
doi: 10.3390/cancers15092607
journal_title: Cancers
journa_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords:
- melanoma
- mutated BRAF
- targeted therapies
- signal transduction
- microenvironment
- resistance
---
